Together with Sanabil 500, Merak Capital, a Saudi-based investment firm with a Capital Market Authority license, is leading a $1.65 million investment round in Hakeem Health. A healthcare technology company called Hakeem Health is creating an AI-powered medical assistant that provides multilingual, real-time, evidence-based clinical insights at the point of care.
HakeemDx, the flagship platform of Hakeem Health, is a clinical decision support engine that interfaces with hospital systems, such as EMRs and lab platforms, to provide clinicians at the point of care with real-time, bilingual (Arabic/English), evidence-based guidance, thereby lowering medical errors and promoting better patient outcomes.
Hakeem Health, which uses recurring contracts to operate on a scalable SaaS model, is aiming for institutional adoption across hospitals, colleges, and healthcare payers.
With over 2,000 hospitals spread across important regional markets like Egypt, Saudi Arabia, and the United Arab Emirates, the company is well-positioned for regional expansion.
With an emphasis on artificial intelligence as a catalyst for innovation, the investment fits with Merak Capital’s plan to assist high-growth technology firms. It also demonstrates the company’s dedication to Saudi Arabia’s Vision 2030, which promotes the growth of knowledge-based industries and digital transformation.
Abdulelah Alshareef, Principal of Venture Capital at Merak Capital, said: “AI is already delivering measurable productivity gains across industries, and healthcare remains a critical area for impact. Hakeem addresses key challenges in clinical decision-making by enabling faster, more accurate assessments that can improve patient outcomes. Backed by a team with deep industry experience, this represents the kind of innovation we are proud to support.”
Bilal Adi, founder and CEO of Hakeem Health, said: “Our mission is to help clinicians make better decisions, faster, so patients receive better care. Merak Capital’s investment reinforces that mission and supports the next phase of our growth. This funding enables us to expand our platform “HakeemDx” across hospitals and health systems in the GCC and continue building AI solutions that clinicians trust.”
As regional healthcare systems increasingly rely on AI to boost clinical efficiency and quality of care, Hakeem Health is well-positioned to accelerate institutional adoption of HakeemDx throughout the GCC with this investment.
